{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:43:24Z","timestamp":1791614604426,"version":"4.3.4"},"reference-count":56,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jiph.2022.11.009","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T21:15:20Z","timestamp":1668201320000},"page":"1477-1483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["N-acetylcysteine for prevention and treatment of COVID-19: Current state of evidence and future directions"],"prefix":"10.1016","volume":"15","author":[{"given":"Jos\u00e9 Luis","family":"Izquierdo-Alonso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"P\u00e9rez-Rial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Gotera","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4436-8443","authenticated-orcid":false,"given":"Germ\u00e1n","family":"Peces-Barba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2022.11.009_bib1","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.jiph.2022.11.009_bib2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jiph.2022.11.009_bib3","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.3389\/fimmu.2020.01648","article-title":"Cytokine storm in COVID-19-immunopathological mechanisms, clinical considerations, and therapeutic approaches: the REPROGRAM consortium position paper","volume":"11","author":"Bhaskar","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jiph.2022.11.009_bib4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/17476348.2018.1495562","article-title":"Multifaceted activity of N-acetyl-l-cysteine in chronic obstructive pulmonary disease","volume":"12","author":"Calzetta","year":"2018","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.jiph.2022.11.009_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/2045-9912.229599","article-title":"Safety and efficacy of N-acetyl-cysteine for prophylaxis of ventilator-associated pneumonia: a randomized, double blind, placebo-controlled clinical trial","volume":"8","author":"Sharafkhah","year":"2018","journal-title":"Med Gas Res"},{"key":"10.1016\/j.jiph.2022.11.009_bib6","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.rmed.2008.09.013","article-title":"The role of glutathione-S-transferase polymorphisms on clinical outcome of ALI\/ARDS patient treated with N-acetylcysteine","volume":"103","author":"Moradi","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.jiph.2022.11.009_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.752939","article-title":"N-acetylcysteine for cardiac protection during coronary artery reperfusion: a systematic review and meta-analysis of randomized controlled trials","volume":"8","author":"Khan","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jiph.2022.11.009_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108544","article-title":"Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine","volume":"219","author":"Ibrahim","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jiph.2022.11.009_bib9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jinf.2021.07.003","article-title":"N-acetylcysteine for the treatment of COVID-19 among hospitalized patients","volume":"84","author":"Avdeev","year":"2022","journal-title":"J Infect"},{"key":"10.1016\/j.jiph.2022.11.009_bib10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jiph.2022.11.009_bib11","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jiph.2022.11.009_bib12","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/joim.13101","article-title":"COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) \u2013 is there any scientific evidence for controversy?","volume":"288","author":"Aleksova","year":"2020","journal-title":"J Intern Med"},{"key":"10.1016\/j.jiph.2022.11.009_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101655","article-title":"Nox2 activation in Covid-19","volume":"36","author":"Violi","year":"2020","journal-title":"Redox Biol"},{"key":"10.1016\/j.jiph.2022.11.009_bib14","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3389\/fimmu.2020.01446","article-title":"The COVID-19 cytokine storm; what we know so far","volume":"11","author":"Ragab","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jiph.2022.11.009_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9111688","article-title":"The potential role of cytokine storm pathway in the clinical course of viral respiratory pandemic","volume":"9","author":"Murdaca","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jiph.2022.11.009_bib16","article-title":"Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19)","volume":"137","author":"Norooznezhad","year":"2021","journal-title":"Micro Res"},{"key":"10.1016\/j.jiph.2022.11.009_bib17","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2147\/TCRM.S273700","article-title":"N-Acetylcysteine to combat COVID-19: an evidence review","volume":"16","author":"Shi","year":"2020","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.jiph.2022.11.009_bib18","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1183\/09031936.97.10071535","article-title":"Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment","volume":"10","author":"De Flora","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiph.2022.11.009_bib19","first-page":"1","article-title":"N-acetylcysteine for COVID-19: a potential adjuvant therapy","volume":"11","author":"Elhidsi","year":"2021","journal-title":"J Heal Sci"},{"key":"10.1016\/j.jiph.2022.11.009_bib20","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2217\/fmb-2020-0074","article-title":"N-acetylcysteine as a potential treatment for COVID-19","volume":"15","author":"Jorge-Aar\u00f3n","year":"2020","journal-title":"Future Microbiol"},{"key":"10.1016\/j.jiph.2022.11.009_bib21","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00408-020-00408-4","article-title":"ACE2: the major cell entry receptor for SARS-CoV-2","volume":"198","author":"Scialo","year":"2020","journal-title":"Lung"},{"key":"10.1016\/j.jiph.2022.11.009_bib22","article-title":"COVID-19 and renin angiotensin aldosterone system: pathogenesis and therapy","volume":"4","author":"Babajani","year":"2021","journal-title":"Heal Sci Rep"},{"key":"10.1016\/j.jiph.2022.11.009_bib23","doi-asserted-by":"crossref","first-page":"13185","DOI":"10.1096\/fj.202001807","article-title":"Rationale for the use of N-acetylcysteine in both prevention and adjuvant therapy of COVID-19","volume":"34","author":"De Flora","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.jiph.2022.11.009_bib24","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1074\/jbc.R111.287995","article-title":"Redox outside the box: linking extracellular redox remodeling with intracellular redox metabolism","volume":"287","author":"Banerjee","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jiph.2022.11.009_bib25","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s10930-020-09935-8","article-title":"Role of oxidative stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) infection: a review","volume":"39","author":"Suhail","year":"2020","journal-title":"Protein J"},{"key":"10.1016\/j.jiph.2022.11.009_bib26","first-page":"12500","article-title":"Could glutathione depletion be the Trojan horse of COVID-19 mortality?","volume":"24","author":"Khanfar","year":"2020","journal-title":"Eur Rev Med Pharm Sci"},{"key":"10.1016\/j.jiph.2022.11.009_bib27","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3390\/antiox9070624","article-title":"The role of glutathione in protecting against the severe inflammatory response triggered by COVID-19","volume":"9","author":"Silvagno","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.jiph.2022.11.009_bib28","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1080\/02770903.2020.1781166","article-title":"Protective effects of N-acetylcysteine on a chemical-induced murine model of asthma","volume":"58","author":"Song","year":"2021","journal-title":"J Asthma"},{"key":"10.1016\/j.jiph.2022.11.009_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20153815","article-title":"Dual role of reactive oxygen species in muscle function: can antioxidant dietary supplements counteract age-related sarcopenia?","volume":"20","author":"Damiano","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jiph.2022.11.009_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11040755","article-title":"The role of oxidative stress in skeletal muscle myogenesis and muscle disease","volume":"11","author":"Lian","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.jiph.2022.11.009_bib31","doi-asserted-by":"crossref","first-page":"34","DOI":"10.5501\/wjv.v10.i2.34","article-title":"Bottom-up analysis of emergent properties of N-acetylcysteine as an adjuvant therapy for COVID-19","volume":"10","author":"Dominari","year":"2021","journal-title":"World J Virol"},{"key":"10.1016\/j.jiph.2022.11.009_bib32","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.2147\/JIR.S306849","article-title":"N-acetylcysteine as adjuvant therapy for COVID-19 \u2013 a perspective on the current state of the evidence","volume":"14","author":"Wong","year":"2021","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.jiph.2022.11.009_bib33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.pcad.2020.02.007","article-title":"Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus","volume":"63","author":"McCarty","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jiph.2022.11.009_bib34","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1089\/ars.2020.8247","article-title":"N-acetylcysteine and hydrogen sulfide in coronavirus disease 2019","volume":"35","author":"Bourgonje","year":"2021","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jiph.2022.11.009_bib35","first-page":"715","article-title":"Where are we with the use of N-acetylcysteine as a preventive and adjuvant treatment for COVID-19?","volume":"26","author":"Di Marco","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jiph.2022.11.009_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.109778","article-title":"N-acetyl-cysteine may prevent COVID-19-associated cytokine storm and acute respiratory distress syndrome","volume":"140","author":"Assimakopoulos","year":"2020","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.jiph.2022.11.009_bib37","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1378\/chest.105.1.190","article-title":"N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study","volume":"105","author":"Suter","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.jiph.2022.11.009_bib38","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1378\/chest.113.6.1616","article-title":"Does N-acetyl-L-cysteine influence cytokine response during early human septic shock?","volume":"113","author":"Spapen","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.jiph.2022.11.009_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics10030271","article-title":"Effect of N-acetylcysteine administration on 30-day mortality in critically Ill patients with septic shock caused by carbapenem-resistant klebsiella pneumoniae and acinetobacter baumannii: a retrospective case-control study","volume":"10","author":"Oliva","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.jiph.2022.11.009_bib40","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/1024907918794559","article-title":"N-acetylcysteine for adults with acute respiratory distress syndrome: a meta-analysis of randomized controlled trials","volume":"26","author":"Lu","year":"2019","journal-title":"Hong Kong J Emerg Med"},{"key":"10.1016\/j.jiph.2022.11.009_bib41","article-title":"Pharmacological agents for adults with acute respiratory distress syndrome","volume":"7","author":"Lewis","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jiph.2022.11.009_bib42","doi-asserted-by":"crossref","first-page":"e736","DOI":"10.1093\/cid\/ciaa1443","article-title":"Double-blind, randomized, placebo-controlled trial with N-acetylcysteine for treatment of severe acute respiratory syndrome caused by coronavirus disease 2019 (COVID-19)","volume":"72","author":"de Alencar","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2022.11.009_bib43","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1007\/s43440-021-00296-2","article-title":"A pilot study on intravenous N-Acetylcysteine treatment in patients with mild-to-moderate COVID19-associated acute respiratory distress syndrome","volume":"73","author":"Taher","year":"2021","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.jiph.2022.11.009_bib44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.18093\/0869-0189-2021-31-1-21-29","article-title":"N-acetylcysteine as a part of complex treatment of moderate COVID-associated pneumonia","volume":"31","author":"Gaynitdinova","year":"2021","journal-title":"Pulmonologiya"},{"key":"10.1016\/j.jiph.2022.11.009_bib45","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1080\/23744235.2021.1945675","article-title":"N-acetyl-cysteine reduces the risk for mechanical ventilation and mortality in patients with COVID-19 pneumonia: a two-center retrospective cohort study","volume":"53","author":"Assimakopoulos","year":"2021","journal-title":"Infect Dis"},{"key":"10.1016\/j.jiph.2022.11.009_bib46","first-page":"147","article-title":"The role of intermediate respiratory care units in preventing ICU collapse during the COVID pandemic","volume":"7","author":"Frades","year":"2020","journal-title":"Int J Respir Pulm Med"},{"key":"10.1016\/j.jiph.2022.11.009_bib47","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1183\/23120541.00542-2021","article-title":"Impact of N-Acetylcysteine on SARS-CoV-2 pneumonia and its sequelae: results from a large cohort study","volume":"8","author":"Faverio","year":"2022","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jiph.2022.11.009_bib48","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.csbj.2021.02.009","article-title":"Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19","volume":"19","author":"Chavarr\u00eda","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.jiph.2022.11.009_bib49","doi-asserted-by":"crossref","DOI":"10.1177\/00368504221074574","article-title":"Use of N-Acetylcysteine at high doses as an oral treatment for patients hospitalized with COVID-19","volume":"105","author":"Izquierdo","year":"2022","journal-title":"Sci Prog"},{"key":"10.1016\/j.jiph.2022.11.009_bib50","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S2213-2600(20)30225-3","article-title":"Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy","volume":"8","author":"George","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jiph.2022.11.009_bib51","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1164\/rccm.201505-1010OC","article-title":"TOLLIP, MUC5B, and the response to N-acetylcysteine among individuals with idiopathic pulmonary fibrosis","volume":"192","author":"Oldham","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiph.2022.11.009_bib52","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40248-016-0039-2","article-title":"N-acetylcysteine in COPD: why, how, and when?","volume":"11","author":"Sanguinetti","year":"2016","journal-title":"Multidiscip Respir Med"},{"key":"10.1016\/j.jiph.2022.11.009_bib53","article-title":"N-acetylcysteine improves oxidative stress and inflammatory response in patients with community acquired pneumonia: a randomized controlled trial","volume":"97","author":"Zhang","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.jiph.2022.11.009_bib54","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.2174\/18734316MTEyyNzY6y","article-title":"The potential mechanism of N-acetylcysteine in Treating COVID-19","volume":"22","author":"Zhou","year":"2021","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.jiph.2022.11.009_bib55","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.21873\/invivo.11946","article-title":"COVID-19: the potential role of copper and N-acetylcysteine (NAC) in a combination of candidate antiviral treatments against SARS-CoV-2","volume":"34","author":"Andreou","year":"2020","journal-title":"Vivo (Brooklyn)"},{"key":"10.1016\/j.jiph.2022.11.009_bib56","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00408-021-00465-3","article-title":"Use of thiols in the treatment of COVID-19: current evidence","volume":"199","author":"Cazzola","year":"2021","journal-title":"Lung"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034122003021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034122003021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:14:03Z","timestamp":1761750843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034122003021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":56,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1876034122003021"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2022.11.009","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-acetylcysteine for prevention and treatment of COVID-19: Current state of evidence and future directions","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2022.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}]}}